Fluorescein-labeled cholera toxin binds detectably to 40-60% of rat mesenteric lymph node cells and induces a temperature-dependent redistribution (patch and cap formation) of cell surface toxin receptors. The redistribution is inhibited by several "metabolic," "microtubule," and "microfilament" inhibitors, by concanavalin A, and by anticholera toxin IgG. Various studies indicate that cholera toxin is at least bivalent, and that this property may be related to both the induction of receptor redistribution and to the activation of adenylate cyclase. Membrane components which are probably identical to the sialo-glycolipid, GM1 ganglioside, appear to be mobile in the plane of the membrane. The possible role of toxin multivalency and receptor mobility in the mechanism of toxin action is considered.
Cholera toxin (choleragen), a protein produced by Vibrio cholerae, activates adenylate cyclase [EC 9.6.1.1; ATP pyrophosphate-lyase (cyclizing)] in all cell types studied (1) . Choleragen binds selectively and with high affinity to cell surface ganglioside GM1 (2-7). Binding is followed by a lag of 20-60 min before activation of adenylate cyclase (8) (9) (10) (11) or of other biological activities (6, 12, 13) is detectable. To obtain more information on the manner by which the toxinreceptor complex, once formed, might produce biological effects, we have studied the interaction of fluorescein-labeled cholera toxin (F-CT) with rat lymphocytes.
MATERIALS AND METHODS
Choleragen was obtained from Dr. C. E. Miller, choleragenoid from Dr. R. A. Finkelstein, gangliosides GM1 and GM2 from Supelco, and GDlb and GA1 from Dr. Peter Fishman. Rabbit anti-cholera toxin was obtained 3 weeks after subcutaneous immunization with 100 ug of toxin emulsified in complete Freund's adjuvant (Difco). [a-32P]ATP was synthesized (11, 14) and purified on DEAE-cellulose. 125I-Labeled toxin, ACi/Aig (6) , and ganglioside-Sepharose derivatives (15) have been described. Fluoresceinated toxin and choleragenoid were prepared by the method of Cebra and Goldstein (16) . Membrane staining of viable lymphocytes with F-CT and examination of stained cells by fluorescence microscopy were done by standard methods (17) .
RESULTS
Binding Properties of F-CT. F-CT retains 80% of its biological activity (lipolysis in isolated fat cells, ref. 6 ). F-CT (10 nM), incubated with viable lymphocytes (107 in 1 ml) at 00 for 30 min, binds to the surface of some of the cells. The binding can be blocked by preincubating the cells with unlabeled choleragen or choleragenoid or by preincubating F-CT with anti-toxin or ganglioside GM1 (Table 1) . Other gangliosides structurally related to GML (i.e., GM2, GA1, Gdlb, and GT1) are ineffective. Thus, F-CT retains the binding and biological properties of native toxin (6) .
Mobility of Lymphocyte Toxin-Receptor Complexes. If lymphocytes incubated at 00 with F-CT are warmed (370) for 20-30 min, the surface fluorescence, which is initially diffuse and patchy (Fig. la) , redistributes and becomes concentrated preferentially at one pole of the cell ( Fig. lb and  c ; Table 2 ), indicating mobility in the plane of the membrane. Binding and redistribution are detectable with 10-10 M F-CT (Fig. 2 ). Since this concentration is well within the linear dose response range for toxin activation of adenylate cyclase in these cells, the binding and redistribution events described most likely reflect the properties of the functionally relevant toxin receptors.
Multivalency of Cholera Toxin. Redistribution of cell surface glycoproteins by antibodies (17, 18) and lectins (19) depends on the multivalent nature of the capping agents. Since lymphocyte-bound cholera toxin can crosslink the cells IgG added at 00 to cells treated with F-CT at 00 inhibits re-'distribution and patching seen on warming to 370 (Fig. 4) . This inhibition is selective for toxin receptors since capping of surface immunoglobulin, detected by rhodamine-labeled anti-rat IgG, is not affected by toxin and anti-toxin IgG (data not shown). The inhibition is dependent on the dose of anti-toxin IgG used (Fig. 4) . The fact that anti-toxin inhibits capping of toxin-receptor complexes may indicate that these complexes are too far apart to be crosslinked by the antibody (20) . This is supported by the observation that goat anti-rabbit Fc can partially reverse the inhibitory effect of anti-toxin IgG (Table 4) . Anti-toxin blocks the ability of toxin-treated cells to crosslink to ganglioside-Sepharose (Table 3) , suggesting that anti-toxin can reduce the effective valence of the cell-bound toxin. Thus, it may be proposed that crosslinking of toxin receptors is required for their redistribution and that toxin multivalency is essential for such reorganizations.
Effect of Agents Which Restrict Capping. Metabolic poi- The experiments were performed as stated in the legend of sons which inhibit capping of membrane glycoproteins (17, 21, 22 ) also inhibit redistribution of toxin receptors (Table  5 ). Depending on the system, microtubule and microfilament inhibitors have been reported to inhibit capping, or to have no effect (23, (24) (25) (26) (27) . The mobility of toxin receptors is inhibited substantially by all the microtubule and microfilament inhibitors tested (Table 5 ) and by concanavalin A, which inhibits mobility of various lymphocyte surface antigens (19, 22 (Table 6 ). The effects of these inhibitors can be grouped into three categories: those which (i) have little or no effect on either basal or toxin-stimulated cyclase activity (colchicine, vinblastine, vincristine, concanavalin A), (ii) affect both activities (NaF, Dnp), and (iii) have little or no effect on basal but markedly reduce toxin-stimulated cyclase Lymphocytes were stained with F-CT and treated with anti-CT IgG as described in Fig. 4 . After washing, cells were treated with the IgG fraction of goat anti-rabbit Fc (IgG), 00, 30 min before being warmed at 370 for various times.
(NaN3 and cytochalasin B). The first inhibitors are not informative since they only partially depress toxin mobility (Table 5 ); sufficient receptor rearrangement or multipoint attachment may still occur to permit enzyme activation. Group 2 inhibitors are not useful since their alteration of basal cyclase activity indicates unrelated effects on membrane properties. Group 3 inhibitors, however, may preferentially affect membrane events involved in toxin activation of cyclase. Although both cytochalasin B and NaN3 partially reduce toxin mobility and rearrangement and partially inhibit toxin activation, lack of knowledge concerning their site(s) of action frustrates interpretations of the interdependence of these two effects.
The effect of multivalent binding and receptor redistribution on cyclase activation was better analyzed with antitoxin IgG, since it is known that the suppression of patching and capping results from specific interaction of the antibody with cell-bound toxin. When anti-toxin IgG is used to restrict redistribution of toxin receptors, enzyme activation is mark- edly inhibited (Table 7) . However, if anti-toxin is added after considerable toxin-receptor reorganization has occurred, the inhibitory effect is diminished. The effect of anti-toxin IgG is abolished by preabsorption with choleragenoid, and nonimmune rabbit IgG has no effect on cyclase activity. Anti-toxin IgG does not inhibit by removing toxin from the cells in excess of the amount that normally dissociates at 37°. F-CT stained cells treated with anti-toxin remain brightly fluorescent.
DISCUSSION
The effect of anti-cholera toxin IgG demonstrates that the interaction of anti-toxin with cell-bound toxin can partially Table 1 ). Capping experiments were as described in Fig. 1 Table 5 .
not reversible if anti-toxin is added as late as 5 min after toxin might be explained in quantitative terms if the residual, unneutralized toxin still generates enough cyclic AMP to produce the biological response. The kinetics of toxin activation of cellular processes (6) and of adenylate cyclase (11) suggest that the toxin binds to the membrane in a biologically inactive form, and that during the lag phase it is converted to an active form (6, 11) . It was speculated (6, 11, 36) that this transformation might involve lateral mobility of toxin-receptor complexes in the plane of the membrane. This report demonstrates that toxinreceptor complexes are indeed mobile in the plane of the membrane, that toxin is at least bivalent, and that the latter property may be related to the observed toxin-receptor redistribution. Anti-toxin reduces the effective valence of cellbound toxin and it inhibits CT patching, capping, and activation of adenylate cyclase. It is suggested that anti-toxin inhibits activation of cyclase by interfering with a rearrangement normally required to convert the inactive toxin-receptor complex to the active form.
Since choleragenoid, a biologically inactive competitive antagonist of toxin action which lacks the 36,000 molecular weight subunit (6) , can induce receptor redistribution as well as toxin (data not shown), receptor crosslinking and rearrangement are not sufficient conditions for stimulation of cyclase. It is possible that multivalent binding places a strain on the toxin molecule, causing it to dissociate into its "active" (36,000 molecular weight) and "binding" subunits. Since the free "active" subunit is quite hydrophobic, it might be readily incorporated into the substance of the membrane, where it may interact with and activate adenylate cyclase (26, 28 
